ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Programs

ACS names its 2020 Heroes of Chemistry

by Linda Wang
May 15, 2020 | APPEARED IN VOLUME 98, ISSUE 19

 

09819-acsnews2-dupont.jpg
Credit: DuPont
A DuPont technician loads a chemical-mechanical planarization pad into a polishing tool.

Four teams of industrial chemical scientists from AST Products, DuPont, and Janssen have won the 2020 Heroes of Chemistry Award, which is the American Chemical Society’s highest honor for industrial chemical scientists.

Started in 1996, the Heroes of Chemistry program recognizes industrial chemical scientists whose innovative work has led to the development of chemistry-based, commercially successful products that have benefited humankind.

“The 2020 Heroes of Chemistry exemplify the spirit of innovation and creativity that is crucial to developing solutions that improve the lives of people worldwide,” says ACS president Luis Echegoyen. “The advances from AST Products, DuPont and Janssen benefit both patients and consumers, and again highlight the importance of the chemical sciences in all areas of industry.”

The team from AST Products is being honored for its development of LubriMATRIX, a surface treatment technology that protects the intraocular lens from damage during cataract surgery. One team from DuPont developed FilmTec, a reverse osmosis technology that has led to cleaner drinking water and other purification techniques. The other team from DuPont developed chemical-mechanical planarization pads that have contributed to advancements in semiconductor fabrication. Finally, the team from Janssen developed Sirturo (bedaquiline) for the treatment of drug-resistant tuberculosis. The drug was approved by the US Food and Drug Administration in 2012.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment